Windward Bio

Round
windwardbio.com Biotech & Healthcare Basel, Switzerland 11–50 employees
Total Funding $200M
Latest Round Undisclosed Round
Last Announced May 5, 2026
Investors 13 Backers
Decision Makers Profile Active

About Windward Bio

Windward Bio develops monoclonal antibodies for advanced immunological diseases.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Round
Global Headquarters Basel, Switzerland
Team Size 11–50 employees
Tracked Since Nov 6, 2026

Web & Domain Identity

Official Website windwardbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Company Profile

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised undisclosed · Round

    fundraisingfox.com

  2. Capital Raise

    Raised $200,000,000 · Series-A

    Backed by Blue Owl Capital

Investors & Backers

13
Blue Owl Capital
Lead
Harbour Biomed
Janus Henderson Investors
Novo Holdings
Omega Funds
OrbiMed
Pivotal bioVenture Partners
Qiming Venture Partners
Quan Capital
RA Capital Management
RTW Investments
Sanofi Ventures
SR One

Funding History

2 Rounds
Round equity · May 5, 2026
Series-A equity · Jan 10, 2025

Round backers: Blue Owl Capital

$200,000,000 globenewswire.com

Founders & Leadership

6

Claudia D’Augusta

Chief Financial Officer

Work email & phone locked Unlock →

Jeffrey Stavenhagen

Chief Scientific Officer

Work email & phone locked Unlock →

Kevin Harris

Chief Operating Officer

Work email & phone locked Unlock →

Luca Santarelli

Founder

Work email & phone locked Unlock →

Omar Khwaja

Chief Medical Officer

Work email & phone locked Unlock →

Scott Applebaum

Chief Legal & Corporate Development Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts